Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Total skin electron beam irradiation (TSEBI) is a radiotherapy technique that modulates the immune system through DNA damage, DAMP release, and cytokine production. While primarily used for cutaneous lymphomas like mycosis fungoides, TSEBI can enhance anti-tumor immunity and potentially synergize with immunotherapies. However, it also carries risks, including acute toxicities and heightened infection susceptibility due to compromised skin integrity. The balance between therapeutic benefit and adverse effects on immunity is crucial.
Induction of DNA damage leading to immunogenic cell death, DAMP release, cytokine modulation, and activation of immune cells.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Modulation via Total Skin Electron Beam Irradiation (None).